{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T19:58:49Z","timestamp":1785873529871,"version":"3.56.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13075-017-1493-8","type":"journal-article","created":{"date-parts":[[2017,12,22]],"date-time":"2017-12-22T13:17:53Z","timestamp":1513948673000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Nonradiographic axial spondyloarthritis: clinical and therapeutic relevance"],"prefix":"10.1186","volume":"19","author":[{"given":"Nilasha","family":"Ghosh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric M.","family":"Ruderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,22]]},"reference":[{"key":"1493_CR1","doi-asserted-by":"crossref","unstructured":"Strand V, Singh JA. Evaluation and management of the patient with suspected inflammatory spine disease. Mayo Clinic Proceedings. 2017;92(4):555\u201364.","DOI":"10.1016\/j.mayocp.2016.12.008"},{"issue":"1","key":"1493_CR2","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/s13075-015-0897-6","volume":"17","author":"JK Wallman","year":"2015","unstructured":"Wallman JK, et al. Comparison of non-radiographic axial spondyloarthritis and ankylosing spondylitis patients\u2014baseline characteristics, treatment adherence, and development of clinical variables during three years of anti-TNF therapy in clinical practice. Arthritis Res Ther. 2015;17(1):378.","journal-title":"Arthritis Res Ther"},{"key":"1493_CR3","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","volume":"76","author":"D Heijde van der","year":"2017","unstructured":"van der Heijde D, et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 2017;76:978\u201391.","journal-title":"Ann Rheum Dis."},{"issue":"4","key":"1493_CR4","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"SVD Linden","year":"1984","unstructured":"Linden SVD, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. Arthritis Rheumatol. 1984;27(4):361\u20138.","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"1493_CR5","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/art.37803","volume":"65","author":"J Sieper","year":"2013","unstructured":"Sieper J, van der Heijde D. Review: nonradiographic axial spondyloarthritis: new definition of an old disease? Arthritis Rheum. 2013;65(3):543\u201351.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"1493_CR6","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2217\/ijr.12.61","volume":"7","author":"S Lipton","year":"2012","unstructured":"Lipton S, Deodhar A. The new ASAS classification criteria for axial and peripheral spondyloarthritis: promises and pitfalls. Int J Clin Rheumatol. 2012;7(6):675\u201382.","journal-title":"Int J Clin Rheumatol"},{"issue":"4","key":"1493_CR7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11926-013-0317-3","volume":"15","author":"WJ Taylor","year":"2013","unstructured":"Taylor WJ, Robinson PC. Classification criteria: peripheral spondyloarthropathy and psoriatic arthritis. Curr Rheumatol Rep. 2013;15(4):317.","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"1493_CR8","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/ard.2009.108217","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis. 2009;68(6):770\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1493_CR9","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, Landewe R, van der Heijde D. SpondyloArthritis international Society (ASAS) classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68(6):777\u201383.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1493_CR10","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/acr.21621","volume":"64","author":"JD Reveille","year":"2012","unstructured":"Reveille JD, Witter JP, Weisman MH. Prevalence of axial spondylarthritis in the United States: estimates from a cross\u2010sectional survey. Arthritis Care Res. 2012;64(6):905\u201310.","journal-title":"Arthritis Care Res"},{"issue":"8","key":"1493_CR11","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/acr.21994","volume":"65","author":"V Strand","year":"2013","unstructured":"Strand V, et al. Prevalence of axial spondyloarthritis in United States rheumatology practices: Assessment of SpondyloArthritis International Society criteria versus rheumatology expert clinical diagnosis. Arthritis Care Res. 2013;65(8):1299\u2013306.","journal-title":"Arthritis Care Res"},{"issue":"1","key":"1493_CR12","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13075-016-1093-z","volume":"18","author":"JJ Winter de","year":"2016","unstructured":"de Winter JJ, et al. Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis. Arthritis Res Ther. 2016;18(1):196.","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"1493_CR13","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/acr.21688","volume":"64","author":"U Kiltz","year":"2012","unstructured":"Kiltz U, et al. Do patients with non\u2010radiographic axial spondylarthritis differ from patients with ankylosing spondylitis? Arthritis Care Res. 2012;64(9):1415\u201322.","journal-title":"Arthritis Care Res"},{"issue":"3","key":"1493_CR14","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/art.24483","volume":"60","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, et al. The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort. Arthritis Rheum. 2009;60(3):717\u201327.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"1493_CR15","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3899\/jrheum.090625","volume":"37","author":"PD Sampaio-Barros","year":"2010","unstructured":"Sampaio-Barros PD, et al. Undifferentiated spondyloarthritis: a long-term follow-up. J Rheumatol. 2010;37(6):1195\u20139.","journal-title":"J Rheumatol"},{"issue":"9","key":"1493_CR16","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1002\/art.39225","volume":"67","author":"D Poddubnyy","year":"2015","unstructured":"Poddubnyy D, et al. Brief report: clinical course over two years in patients with early nonradiographic axial spondyloarthritis and patients with ankylosing spondylitis not treated with tumor necrosis factor blockers: results from the German Spondyloarthritis Inception Cohort. Arthritis Rheumatol. 2015;67(9):2369\u201375.","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"1493_CR17","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/annrheumdis-2012-202389","volume":"72","author":"I-H Song","year":"2013","unstructured":"Song I-H, et al. Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after 1\u00a0year of treatment with etanercept: results from the ESTHER trial. Ann Rheum Dis. 2013;72(6):823\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"1493_CR18","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1136\/ard.2010.145995","volume":"70","author":"D Poddubnyy","year":"2011","unstructured":"Poddubnyy D, et al. Rates and predictors of radiographic sacroiliitis progression over 2\u00a0years in patients with axial spondyloarthritis. Ann Rheum Dis. 2011;70(8):1369\u201374.","journal-title":"Ann Rheum Dis"},{"key":"1493_CR19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/annrheumdis-2013-204231","volume":"73","author":"R Landewe","year":"2014","unstructured":"Landewe R, et al. Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled phase 3 study. Ann Rheum Dis. 2014;73:39\u201347.","journal-title":"Ann Rheum Dis."},{"key":"1493_CR20","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/annrheumdis-2015-208852","volume":"75","author":"A Deodhar","year":"2016","unstructured":"Deodhar A, et al. The term \u2018non-radiographic axial spondyloarthritis\u2019 is much more important to classify than to diagnose patients with axial spondyloarthritis. Ann Rheum Dis. 2016;75:791\u20134.","journal-title":"Ann Rheum Dis."},{"issue":"12","key":"1493_CR21","first-page":"2286","volume":"21","author":"S Garrett","year":"1994","unstructured":"Garrett S, et al. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 1994;21(12):2286\u201391.","journal-title":"J Rheumatol"},{"issue":"12","key":"1493_CR22","first-page":"2281","volume":"21","author":"A Calin","year":"1994","unstructured":"Calin A, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol. 1994;21(12):2281\u20135.","journal-title":"J Rheumatol"},{"issue":"4","key":"1493_CR23","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/BOR.0b013e3283470f23","volume":"23","author":"P Machado","year":"2011","unstructured":"Machado P, van der Heijde D. How to measure disease activity in axial spondyloarthritis? Curr Opin Rheumatol. 2011;23(4):339\u201345.","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"1493_CR24","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1002\/art.33465","volume":"64","author":"D Poddubnyy","year":"2012","unstructured":"Poddubnyy D, et al. Baseline radiographic damage, elevated acute\u2010phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis. Arthritis Rheum. 2012;64(5):1388\u201398.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"1493_CR25","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1136\/annrheumdis-2011-201252","volume":"71","author":"D Poddubnyy","year":"2012","unstructured":"Poddubnyy D, et al. Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort. Ann Rheum Dis. 2012;71(10):1616\u201322.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"1493_CR26","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1002\/art.39257","volume":"67","author":"J Sieper","year":"2015","unstructured":"Sieper J, et al. A randomized, double\u2010blind, placebo\u2010controlled, sixteen\u2010week study of subcutaneous golimumab in patients with active nonradiographic axial spondyloarthritis. Arthritis Rheumatol. 2015;67(10):2702\u201312.","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"1493_CR27","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1136\/annrheumdis-2012-201766","volume":"72","author":"J Sieper","year":"2013","unstructured":"Sieper J, et al. Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1). Ann Rheum Dis. 2013;72(6):815\u201322.","journal-title":"Ann Rheum Dis"},{"key":"1493_CR28","doi-asserted-by":"crossref","first-page":"S1052","DOI":"10.1002\/acr.21952","volume":"65","author":"E Ruderman","year":"2013","unstructured":"Ruderman E, et al. Spondyloarthritis Epidemiology and Burden Phase 2 [speed 2] Study: Disease progression in axial spondyloarthropathy (SpA). Arthritis Rheum. 2013;65:S1052\u20133.","journal-title":"Arthritis Rheum."},{"issue":"6","key":"1493_CR29","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/art.39542","volume":"68","author":"R Wang","year":"2016","unstructured":"Wang R, Gabriel SE, Ward MM. Progression of nonradiographic axial spondyloarthritis to ankylosing spondylitis: a population\u2010based cohort study. Arthritis Rheumatol. 2016;68(6):1415\u201321.","journal-title":"Arthritis Rheumatol"},{"key":"1493_CR30","doi-asserted-by":"crossref","unstructured":"Dougados M, Sepriano A, Molto A, Ramiro S, de Hooge M, Van Den Berg R, Navarro Compan V, De Mattei C, Landew\u00e9 R, Van der Heijde D. Evaluation of the changes in structural damage in axial spondyloarthritis on plain pelvic radiographs: the 5\u00a0years data of the DESIR cohort. Ann Rheum Dis. 2017;76(supplement 2):100.","DOI":"10.1136\/annrheumdis-2017-211596"},{"issue":"9","key":"1493_CR31","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/acr.22001","volume":"65","author":"A Tournadre","year":"2013","unstructured":"Tournadre A, et al. Differences between women and men with recent\u2010onset axial spondyloarthritis: results from a prospective multicenter french cohort. Arthritis Care Res. 2013;65(9):1482\u20139.","journal-title":"Arthritis Care Res"},{"issue":"9","key":"1493_CR32","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00296-007-0344-3","volume":"27","author":"V Aloush","year":"2007","unstructured":"Aloush V, et al. Fibromyalgia in women with ankylosing spondylitis. Rheumatol Int. 2007;27(9):865\u20138.","journal-title":"Rheumatol Int"},{"issue":"5","key":"1493_CR33","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/ard.2006.060293","volume":"66","author":"W Lee","year":"2007","unstructured":"Lee W, et al. Are there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort. Ann Rheum Dis. 2007;66(5):633\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"1493_CR34","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s10067-011-1719-0","volume":"30","author":"G Slobodin","year":"2011","unstructured":"Slobodin G, et al. Recently diagnosed axial spondyloarthritis: gender differences and factors related to delay in diagnosis. Clin Rheumatol. 2011;30(8):1075\u201380.","journal-title":"Clin Rheumatol"},{"key":"1493_CR35","unstructured":"Ciurea AHM, Weber U, Tamborrini G, Micheroli R, Wildi L, Zufferey P, Nissen MJ, Villiger PM, Bernhard J, van der Heijde D, Landew\u00e9 RBM, Scherer A, Exer P. In contrast to men, women with nonradiographic axial spondyloarthritis have lower response rates to TNF inhibitors than women with ankylosing spondylitis. ACR. 2016;2016:Abstract 699."},{"issue":"2","key":"1493_CR36","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.berh.2010.01.011","volume":"25","author":"F Atzeni","year":"2011","unstructured":"Atzeni F, et al. Chronic widespread pain in the spectrum of rheumatological diseases. Best Pract Res Clin Rheumatol. 2011;25(2):165\u201371.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"8","key":"1493_CR37","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00296-014-2955-9","volume":"34","author":"F Salaffi","year":"2014","unstructured":"Salaffi F, et al. Fibromyalgia in patients with axial spondyloarthritis: epidemiological profile and effect on measures of disease activity. Rheumatol Int. 2014;34(8):1103\u201310.","journal-title":"Rheumatol Int"},{"issue":"7","key":"1493_CR38","first-page":"1415","volume":"29","author":"S Heikkil\u00e4","year":"2002","unstructured":"Heikkil\u00e4 S, et al. Functional impairment in spondyloarthropathy and fibromyalgia. J Rheumatol. 2002;29(7):1415\u20139.","journal-title":"J Rheumatol"},{"issue":"2","key":"1493_CR39","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/art.39298","volume":"68","author":"MM Ward","year":"2016","unstructured":"Ward MM, et al. American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Rheumatol. 2016;68(2):282\u201398.","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"1493_CR40","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1136\/annrheumdis-2012-203148","volume":"72","author":"D Poddubnyy","year":"2013","unstructured":"Poddubnyy D, et al. Cigarette smoking has a dose-dependent impact on progression of structural damage in the spine in patients with axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort (GESPIC). Ann Rheum Dis. 2013;72(8):1430\u20132.","journal-title":"Ann Rheum Dis"},{"key":"1493_CR41","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1136\/annrheumdis-2013-205133","volume":"75","author":"A Ciurea","year":"2016","unstructured":"Ciurea A, et al. Impaired response to treatment with tumour necrosis factor \u03b1 inhibitors in smokers with axial spondyloarthritis. Ann Rheum Dis. 2016;75:532\u20139.","journal-title":"Ann Rheum Dis."},{"issue":"3","key":"1493_CR42","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3899\/jrheum.150721","volume":"43","author":"FP Kroon","year":"2016","unstructured":"Kroon FP, et al. Nonsteroidal antiinflammatory drugs for axial spondyloarthritis: a Cochrane review. J Rheumatol. 2016;43(3):607\u201317.","journal-title":"J Rheumatol"},{"issue":"Suppl 2","key":"1493_CR43","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/annrheumdis-2015-eular.3086","volume":"74","author":"G Varkas","year":"2015","unstructured":"Varkas G, et al. OP0170 treatment of axial spondyloarthritis with an optimal dosage of nsaids: a 6-week follow up study focusing on magnetic resonance imaging of the sacroiliac joints. Ann Rheum Dis. 2015;74 Suppl 2:134.","journal-title":"Ann Rheum Dis"},{"key":"1493_CR44","doi-asserted-by":"crossref","first-page":"j1909","DOI":"10.1136\/bmj.j1909","volume":"357","author":"M Bally","year":"2017","unstructured":"Bally M, et al. Risk of acute myocardial infarction with NSAIDs in real world use: Bayesian meta-analysis of individual patient data. BMJ. 2017;357:j1909.","journal-title":"BMJ."},{"issue":"5","key":"1493_CR45","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.tem.2009.12.004","volume":"21","author":"KA Blackwell","year":"2010","unstructured":"Blackwell KA, Raisz LG, Pilbeam CC. Prostaglandins in bone: bad cop, good cop? Trends Endocrinol Metab. 2010;21(5):294\u2013301.","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"1493_CR46","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/ard.2007.075309","volume":"67","author":"J Sieper","year":"2008","unstructured":"Sieper J, et al. Comparison of two different dosages of celecoxib with diclofenac for the treatment of active ankylosing spondylitis: results of a 12-week randomised, double-blind, controlled study. Ann Rheum Dis. 2008;67(3):323\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1493_CR47","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/art.21054","volume":"52","author":"A Wanders","year":"2005","unstructured":"Wanders A, et al. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum. 2005;52(6):1756\u201365.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1493_CR48","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/art.24408","volume":"60","author":"N Barkham","year":"2009","unstructured":"Barkham N, et al. Clinical and imaging efficacy of infliximab in HLA-B27-positive patients with magnetic resonance imaging-determined early sacroiliitis. Arthritis Rheumatol. 2009;60(4):946\u201354.","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"1493_CR49","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1002\/art.23606","volume":"58","author":"H Haibel","year":"2008","unstructured":"Haibel H, et al. Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: results of a twelve\u2010week randomized, double\u2010blind, placebo\u2010controlled trial followed by an open\u2010label extension up to week fifty\u2010two. Arthritis Rheum. 2008;58(7):1981\u201391.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1493_CR50","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/art.20852","volume":"52","author":"D Heijde van der","year":"2005","unstructured":"van der Heijde D, et al. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo\u2010controlled trial (ASSERT). Arthritis Rheumatol. 2005;52(2):582\u201391.","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"1493_CR51","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/art.38721","volume":"66","author":"M Dougados","year":"2014","unstructured":"Dougados M, et al. Symptomatic efficacy of etanercept and its effects on objective signs of inflammation in early nonradiographic axial spondyloarthritis: a multicenter, randomized, double\u2010blind, placebo\u2010controlled trial. Arthritis Rheumatol. 2014;66(8):2091\u2013102.","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"1493_CR52","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/ard.2010.139667","volume":"70","author":"I Song","year":"2011","unstructured":"Song I, et al. Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial. Ann Rheum Dis. 2011;70(4):590\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"1493_CR53","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1002\/art.23969","volume":"58","author":"RD Inman","year":"2008","unstructured":"Inman RD, et al. Efficacy and safety of golimumab in patients with ankylosing spondylitis: results of a randomized, double-blind, placebo-controlled, phase III trial. Arthritis Rheum. 2008;58(11):3402\u201312.","journal-title":"Arthritis Rheum"},{"key":"1493_CR54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmed.2017.00001","volume":"4","author":"PP Cheung","year":"2017","unstructured":"Cheung PP. Anti-IL17A in axial spondyloarthritis\u2014where are we at? Front Med. 2017;4:1.","journal-title":"Front Med."},{"issue":"26","key":"1493_CR55","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1056\/NEJMoa1505066","volume":"373","author":"D Baeten","year":"2015","unstructured":"Baeten D, et al. Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis. N Engl J Med. 2015;373(26):2534\u201348.","journal-title":"N Engl J Med"},{"issue":"7","key":"1493_CR56","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1002\/art.21913","volume":"54","author":"D Heijde van der","year":"2006","unstructured":"van der Heijde D, et al. Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2006;54(7):2136\u201346.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"1493_CR57","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1002\/art.11325","volume":"48","author":"JC Davis","year":"2003","unstructured":"Davis JC, et al. Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial. Arthritis Rheumatol. 2003;48(11):3230\u20136.","journal-title":"Arthritis Rheumatol"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-017-1493-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T14:27:14Z","timestamp":1570544834000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-017-1493-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1493"],"URL":"https:\/\/doi.org\/10.1186\/s13075-017-1493-8","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"286"}}